Top

Published in:

Open Access 01-12-2020 | Acute Respiratory Distress-Syndrome | Research Letter

Neuromuscular blocking agents (NMBA) for COVID-19 acute respiratory distress syndrome: a multicenter observational study

Authors: Romain Courcelle, Stéphane Gaudry, Nicolas Serck, Gauthier Blonz, Jean-Baptiste Lascarrou, David Grimaldi, on behalf the COVADIS study group

Published in: Critical Care | Issue 1/2020

Excerpt

Dear Editor, …

National Heart L, Blood Institute PCTN, Moss M, Huang DT, Brower RG, Ferguson ND, et al. Early neuromuscular blockade in the acute respiratory distress syndrome. N Engl J Med. 2019;380(21):1997–2008.CrossRef

Papazian L, Forel JM, Gacouin A, et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med. 2010;363:1107–16. https://doi.org/10.1056/NEJMoa1005372.CrossRefPubMed

Papazian L, Aubron C, Brochard L, et al. Formal guidelines: management of acute respiratory distress syndrome. Ann. Intensive Care. 2019;9:69. https://doi.org/10.1186/s13613-019-0540-9.CrossRefPubMedPubMedCentral

Gattinoni L, Chiumello D, Rossi S. COVID-19 pneumonia: ARDS or not? Crit Care. 2020;24:154. https://doi.org/10.1186/s13054-020-02880-z..CrossRefPubMedPubMedCentral

Edward J, Schenck KH, Goyal P, et al. Respiratory mechanics and gas exchange in COVID-19 associated respiratory failure. Am J Respir Crit Care Med. 2020. https://doi.org/10.1513/AnnalsATS.202005-427RL.

LUNG SAFE investigators. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA. 2016;315(8):788–800. https://doi.org/10.1001/jama.2016.0291.CrossRef

Title: Neuromuscular blocking agents (NMBA) for COVID-19 acute respiratory distress syndrome: a multicenter observational study
Authors: Romain Courcelle
Stéphane Gaudry
Nicolas Serck
Gauthier Blonz
Jean-Baptiste Lascarrou
David Grimaldi
on behalf the COVADIS study group
Publication date: 01-12-2020
Publisher: BioMed Central
Keywords: Acute Respiratory Distress-Syndrome
COVID-19
Published in: Critical Care / Issue 1/2020
Electronic ISSN: 1364-8535
DOI: https://doi.org/10.1186/s13054-020-03164-2

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Neuromuscular blocking agents (NMBA) for COVID-19 acute respiratory distress syndrome: a multicenter observational study

Excerpt

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2020

The Adaptive COVID-19 Treatment Trial-1 (ACTT-1) in a real-world population: a comparative observational study

RNA-expression of adrenomedullin is increased in patients with severe COVID-19

Should we use angiotensin II infusion in COVID-19-associated vasoplegic shock?

Sublingual microcirculation does not reflect red blood cell transfusion thresholds in the intensive care unit—a prospective observational study in the intensive care unit

Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMO

Should the ultrasound probe replace your stethoscope? A SICS-I sub-study comparing lung ultrasound and pulmonary auscultation in the critically ill